Finally, we detected typically strong cytoplasmic staining in 54/58 (93%) cancerous thyroid samples, while only 14/62 (23%) of the NAT samples showed almost exclusively weak signals (HThy‐Pap120CS‐01; Fig. 8E cancer samples A1/B1 and A3/B3 and normal adjacent tissue A2/B2 and A4/B4). This evidence concerns the gene BRD2 and cancer.